Sarvin Sanaie, Narges Koohi, Reza Mosaddeghi-Heris, Shirin Rezai, Elahe Movagharnia, Hanie Karimi, Seyedehyasmin Moghaddamziabari, Sina Hamzehzadeh, Elnaz Gholipour-Khalili, Mahnaz Talebi, Amirreza Naseri
BACKGROUND: Cognitive impairment is highly prevalent in multiple sclerosis (MS) with poorly understood underlying mechanisms. Lipids are considered to be associated with MS progression through the inflammatory and oxidative stress pathways, brain atrophy, cellular signaling, and tissue physiology. In addition, serum lipids are proposed as a modifiable factor affecting the neuropsychiatric condition; therefore, this study aims to assess the association between serum lipid levels and cognitive outcomes in MS...
February 29, 2024: Multiple Sclerosis and related Disorders